Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 119 for “"CTLA4"”.
-
Investigating transendocytosis mediated by CTLA4
… Cytotoxic T-lymphocyte-associated protein 4 (CTLA4), a co-inhibitory receptor that is constitutively expressed in Treg cells, is well-evidenced to be the major protein responsible for the ligand depletion ability of Treg cells. While sharing the same ligands with CD28 (CD80 and CD86) but with …
-
Assoziationsuntersuchung von Polymorphismen des CTLA4- und PTPN22-Gens mit Morbus Menière
… das Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)-Gen und das Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (PTPN22)-Gen. CTLA4 gehört zu den T-Zellrezeptormolekülen und spielt eine wichtige hemmende Rolle bei der T-Zell-vermittelten Immunantwort. Bei PTPN22 handelt es sich …
-
CTLA4 and CLEC16A in Type 1 Diabetes - Looking behind the association
… we examined two different genes in this manner, Ctla4 and Clec16a. A type 1 diabetes associated polymorphism in the CTLA4 gene had been found to alter the splicing ratio of its variants soluble CTLA-4 (sCTLA-4) and full length CTLA-4, the associated allele producing less sCTLA-4 than the …
-
THE ROLE OF INTERFERON GAMMA AND CTLA4 IN MELANOCYTE AND MELANOMA BIOLOGY
… tyrosinase via post-translational mechanisms. CTLA4 is a cell surface receptor on T cells that functions as an immune checkpoint molecule to enforce tolerance to cognate antigens. Anti-CTLA4 immunotherapy is highly effective at reactivating T cell responses against melanoma, which is postulated …
-
Ο ρόλος των μεταλλάξεων των γονιδίων TACI και CTLA4 στην κοινή ποικίλη ανοσοανεπάρκεια
… autoimmune cytopenias. Likewise, the presence of CTLA4 mutations in patients with CVID-like clinical phenotype has been correlated with an increased susceptibility to lymphoproliferation and autoimmune manifestations. The aim of our study was to evaluate the prevalence and any correlations of TACI …
-
Der Einfluss verlängerter Ischämie auf Nierentransplantatfunktion und antigen- abhängige Immunantwort nach Empfängerbehandlung mit CTLA4-Ig
… ist der Einsatz monoklonaler Antikörper wie CTLA4-Ig. Unabhängig von einer eventuell erreichbaren Toleranzinduktion bliebe der I/R-Schaden als antigen- unabhängiger Faktor bestehen. Seine mögliche Interaktion mit einer Toleranzinduktion durch CTLA4-Ig und dessen Folgen für …
-
CTLA4 gene polymorphisms in autoimmune hepatitis (AIH) : gene and clinical disease correlations in South African patients
Also available online. Includes bibliographical references (leaves 76-85).
-
Humanized mouse model: a system to study the interactions of human immune system with vaccinia virus-infected human tumors in mice
… and -1h377 kodiert das Gen für den menschlichen CTLA4-blockierenden Einzelketten-Antikörper (CTLA4 scAb). Befunde aus Replikations- and Zytotoxizitätsstudien zeigten, dass alle sechs Viren Tumorzellen infizieren, sich in ihnen replizieren und sie in Zellkultur schließlich ebenso dosis- und …
-
Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients
… Anti-cytotoxic T-lymphocyte antigen 4 (anti-CTLA4) antibody (ipilimumab) and anti-programmed cell death 1(anti-PD1) antibodies (nivolumab and pembrolizumab), have been shown to have a beneficial effect in treating melanoma but their risk of immune-related hypothyroidism (ir-hypothyroidism) in …
-
Delineation of the mechanisms that promote the tolerogenic properties of dendritic cells in autoimmune diseases
… and T-cell co-stimulation molecule blockade (CTLA4-Ig). Nevertheless, data from registries and cohort studies have shown that in clinical practice, 50-60% of RA patients starting a bDMARD will stop treatment due to inefficacy or toxicity in the long-term, while clinical response, remission or …
-
Klinische Erforschung der CTLA-4-Insuffizienz
… in Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) beeinträchtigen die suppressive Funktion von regulatorischen T-Zellen im menschlichen Immunsystem. Dadurch kommt es zu einer überschießenden Immunantwort und Fehlregulationen, vor allem bei Interaktionen des zellulären Immunsystems. Klinisch …
-
Determinants Of Adaptive Immunity In Cancer
… with metastatic melanoma treated with anti-CTLA4 antibody and radiation (RT) and reproduced this effect in mouse models. Although combined treatment improved responses in irradiated and unirradiated tumors, resistance was common due to upregulation of PD-L1 on tumor cells and corresponding T …
-
Clinical and Cellular Response to Abatacept Therapy and Haematopoietic Stem Cell Transplantation in LRBA Deficiency
… function of regulatory T cells where it traffics CTLA4 to the cell surface, and prevents its lysosomal degradation. CTLA4 is an inhibitory receptor that competes with CD28 to bind CD80/CD86 on antigen presenting cells, thus preventing T cell activation. By interaction with CTLA4, LRBA plays an …
-
Bacteria-based cancer immunotherapy: A re-emerging strategy with contemporary implications
… or cytotoxic T-lymphocyte-associated protein 4 (CTLA4), have been paradigm-shifting advances in medical oncology. However, therapy response rates need improvement, and important questions remain regarding the mechanisms by which checkpoint therapies promote their therapeutic effects. One …
-
LIPID NANOPARTICLE-MEDIATED DELIVERY OF ENHANCED COSTIMULATION BLOCKADE TO PREVENT TYPE 1 DIABETES
… blocking the CD28 pathway via administration of CTLA4-Ig is a promising approach, but recent observations suggest its efficacy is antagonized by inflammatory factors. As antigen presenting cells malfunctions and aberrant accumulation of type 1 interferons are associated with T1D, we pose that …
-
Targeted Combination Therapy Of Triple-Negative Breast Cancer
… inhibitors, namely blockades for CD73, CTLA4 and PD-L1 in combination with LipoDoxAtz to assess reduction in tumor growth. Owing to the possibility that antiPD-L1 and antiCTLA4 act at different stages of the cancer immunity cycle, with CTLA4 blockade at the earlier stage than PD-L1 …
Page 1 of 6